0003-2560-16 – Aztreonam
Firm: E.R. Squibb & Sons, L.L.C.
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2560-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
|
0003-2570-16 – Aztreonam
Firm: E.R. Squibb & Sons, L.L.C.
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2570-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
|
0006-5073-01 – Clesrovimab
Firm: Merck Sharp & Dohme LLC
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0006-5073-01) / .7 mL in 1 SYRINGE, GLASS (0006-5073-99)
|
0006-5073-02 – Clesrovimab
Firm: Merck Sharp & Dohme LLC
Package Description: 10 SYRINGE, GLASS in 1 CARTON (0006-5073-02) / .7 mL in 1 SYRINGE, GLASS (0006-5073-99)
|
|
|
|
0024-5908-01 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5908-01) / 1.14 mL in 1 SYRINGE (0024-5908-00)
|
0024-5908-02 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5908-02) / 1.14 mL in 1 SYRINGE
|
0024-5910-01 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5910-01) / 1.14 mL in 1 SYRINGE (0024-5910-00)
|
0024-5910-02 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5910-02) / 1.14 mL in 1 SYRINGE
|
0024-5920-01 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5920-01) / 1.14 mL in 1 SYRINGE (0024-5920-00)
|
0024-5920-02 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRINGE
|
0024-5922-01 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5922-01) / 1.14 mL in 1 SYRINGE (0024-5922-00)
|
0024-5922-02 – Sarilumab
Firm: Sanofi-Aventis U.S. LLC
Package Description: 2 SYRINGE in 1 PACKAGE (0024-5922-02) / 1.14 mL in 1 SYRINGE
|
0069-0274-30 – Etrasimod
Firm: Pfizer Laboratories Div Pfizer Inc
Package Description: 1 BOTTLE in 1 CARTON (0069-0274-30) / 30 TABLET, FILM COATED in 1 BOTTLE
|
|
|
|
0078-0669-13 – Ofatumumab
Firm: Novartis Pharmaceuticals Corporation
Package Description: 3 VIAL, SINGLE-USE in 1 CARTON (0078-0669-13) / 5 mL in 1 VIAL, SINGLE-USE (0078-0669-61)
|
0078-0690-61 – Ofatumumab
Firm: Novartis Pharmaceuticals Corporation
Package Description: 50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)
|
0078-1007-68 – Ofatumumab
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS
|